Yesterday, Nov. 24, 2015, 106 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $189.51 to $48,391,506.50.

Highlighted Stocks Traded by Insiders:

Parexel International (PRXL) - FREE Research Report

Holdener Eduard E., who is Director at Parexel International, sold 2,200 shares at $67.66 on Nov. 24, 2015. Following this transaction, the Director owned 13,171 shares meaning that the stake was reduced by 14.31% with the 2,200-share transaction.

The shares most recently traded at $68.05, up $0.39, or 0.57% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 455
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 455
  • 12-Week # shares sold: 1,500
  • 24-Week # shares bought: 455
  • 24-Week # shares sold: 2,830

The average volume for Parexel International has been 568,900 shares per day over the past 30 days. Parexel International has a market cap of $3.6 billion and is part of the health care sector and health services industry. Shares are up 22.21% year-to-date as of the close of trading on Tuesday.

PAREXEL International Corp, a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 28.0. Currently, there are 6 analysts who rate Parexel International a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings

rates Parexel International as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Parexel International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Enterprise Bancorp (EBTC) - FREE Research Report

Hanson Eric W, who is Director at Enterprise Bancorp, sold 4,757 shares at $24.29 on Nov. 24, 2015. Following this transaction, the Director owned 386,836 shares meaning that the stake was reduced by 1.21% with the 4,757-share transaction.

The shares most recently traded at $23.99, down $0.30, or 1.26% since the insider transaction. Historical insider transactions for Enterprise Bancorp go as follows:

  • 4-Week # shares bought: 135
  • 4-Week # shares sold: 3,628
  • 12-Week # shares bought: 135
  • 12-Week # shares sold: 3,628
  • 24-Week # shares bought: 435
  • 24-Week # shares sold: 4,128

The average volume for Enterprise Bancorp has been 5,500 shares per day over the past 30 days. Enterprise Bancorp has a market cap of $248.6 million and is part of the financial sector and banking industry. Shares are down 5.74% year-to-date as of the close of trading on Tuesday.

Enterprise Bancorp, Inc. operates as the bank holding company for Enterprise Bank and Trust Company that provides various banking products and services primarily in the Merrimack Valley and North Central regions of Massachusetts and Southern New Hampshire. The stock currently has a dividend yield of 2.08%. The company has a P/E ratio of 16.1.

Exclusive Offer: Get the latest Stock Analysis on EBTC - FREE

TheStreet Quant Ratings

rates Enterprise Bancorp as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Enterprise Bancorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Quaker Chemical (KWR) - FREE Research Report

Caldwell Donald R, who is Director at Quaker Chemical, sold 500 shares at $82.88 on Nov. 24, 2015. Following this transaction, the Director owned 10,552 shares meaning that the stake was reduced by 4.52% with the 500-share transaction.

The shares most recently traded at $83.88, up $1.00, or 1.19% since the insider transaction. Historical insider transactions for Quaker Chemical go as follows:

  • 4-Week # shares sold: 2,608
  • 12-Week # shares sold: 2,608
  • 24-Week # shares sold: 16,621

The average volume for Quaker Chemical has been 75,000 shares per day over the past 30 days. Quaker Chemical has a market cap of $1.1 billion and is part of the basic materials sector and chemicals industry. Shares are down 8.41% year-to-date as of the close of trading on Tuesday.

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for various heavy industrial and manufacturing applications worldwide. The stock currently has a dividend yield of 1.54%. The company has a P/E ratio of 21.2. Currently, there is 1 analyst who rates Quaker Chemical a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KWR - FREE

TheStreet Quant Ratings

rates Quaker Chemical as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Quaker Chemical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.